Report cover image

Global Biological Safety Testing Market Report and Forecast 2024-2032

Publisher Expert Market Research
Published Feb 08, 2024
Length 160 Pages
SKU # EMAR18558255

Description

Global Biological Safety Testing Market Report and Forecast 2024-2032


Global Biological Safety Testing Market Report and Forecast 2024-2032

Global Biological Safety Testing Market Outlook

The global biological safety testing market size was valued at USD 4.53 billion in 2023, driven by innovation of testing technologies across the globe. The market size is anticipated to grow at a CAGR of 13.2% during the forecast period of 2024-2032 to achieve a value of USD 20.03 billion by 2032.

Biological Safety Testing: Introduction

Biological safety testing is a crucial process in the biopharmaceutical industry, ensuring that products such as vaccines, therapeutics, and medical devices are free from harmful contaminants like bacteria, viruses, and toxins. This testing involves a series of rigorous procedures, including sterility tests, endotoxin analyses, and mycoplasma detection, aimed at verifying product safety and compliance with regulatory standards. It's essential for protecting patient health and maintaining the integrity and quality of biomedical products.

Key Trends in the Global Biological Safety Testing Market

There's a growing emphasis on regulatory compliance across the globe, leading to more stringent safety testing requirements for biopharmaceutical products. This trend is driving the demand for biological safety testing services.

Innovations in testing technologies, such as rapid microbiological methods (RMM) and high-throughput screening, are enhancing the efficiency and accuracy of biological safety testing.

The increasing production of biologics, including vaccines, monoclonal antibodies, and cell and gene therapies, is driving the need for comprehensive safety testing to ensure product quality and patient safety.

Many biopharmaceutical companies are outsourcing safety testing to specialized laboratories to reduce costs and leverage technical expertise, leading to the growth of the contract testing market.

Events like the COVID-19 pandemic have highlighted the importance of ensuring biological safety, leading to increased investment in safety testing for vaccines and therapeutics.

Global Biological Safety Testing Market Segmentation

Market Breakup by Product Type
  • Reagents and Kits
  • Instruments
  • Other Products
Market Breakup by Test
  • Sterility Tests
  • Bioburden Tests
  • Endotoxin Tests
  • Other Tests
Market Breakup by Application
  • Vaccines and Therapeutics
  • Cellular and Gene Therapy
  • Blood and Blood-Based Therapy
  • Other Applications
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Biological Safety Testing Market Overview

North America is likely to dominate the market due to stringent regulatory standards, a well-established biopharmaceutical industry, and significant investment in research and development. The United States, in particular, is a hub for innovation in biological safety testing technologies.

Europe shows strong growth, driven by robust healthcare systems, comprehensive regulatory frameworks, and a focus on maintaining high safety standards for pharmaceuticals and medical devices. Countries like Germany, the UK, and France are key contributors.

Asia-Pacific experiences rapid growth due to increasing investment in healthcare, rising demand for biopharmaceutical products, and improving regulatory landscapes. Countries like China, Japan, and India are investing heavily in healthcare infrastructure and research, contributing to market growth.

Latin America is an emerging market with growing potential, driven by improvements in healthcare infrastructure, rising investment in the biopharmaceutical sector, and increasing awareness about product safety and quality.

Middle East & Africa shows gradual growth, influenced by increasing investment in healthcare infrastructure, efforts to standardize regulatory frameworks, and a rising focus on healthcare quality and safety.

Global Biological Safety Testing Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The Avance Biosciences
  • Avance Biosciences
  • Cytovance Biologics
  • Eurofins Scientific
  • Lonza
  • Merck KGaA
  • Promega Corporation
  • Thermo Fisher Scientific
  • Toxikon
  • WuXi AppTec
  • Biomerieux SA
  • Nelson Laboratories, LLC
  • Almac Group
  • GenScript
  • InvivoGen
  • Maravai LifeSciences
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.

Table of Contents

160 Pages
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biological Safety Testing Market Overview
3.1 Global Biological Safety Testing Market Historical Value (2017-2023)
3.2 Global Biological Safety Testing Market Forecast Value (2024-2032)
4 Global Biological Safety Testing Market Landscape
4.1 Global Biological Safety Testing Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biological Safety Testing Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Biological Safety Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biological Safety Testing Market Segmentation
6.1 Global Biological Safety Testing Market by Product Type
6.1.1 Market Overview
6.1.2 Reagents and Kits
6.1.3 Instruments
6.1.4 Other Products
6.2 Global Biological Safety Testing Market by Test
6.2.1 Market Overview
6.2.2 Sterility Tests
6.2.3 Bioburden Tests
6.2.4 Endotoxin Tests
6.2.5 Other Tests
6.3 Global Biological Safety Testing Market by Application
6.3.1 Market Overview
6.3.2 Vaccines and Therapeutics
6.3.3 Cellular and Gene Therapy
6.3.4 Blood and Blood-Based Therapy
6.3.5 Other Applications
6.4 Global Biological Safety Testing Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Biological Safety Testing Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Biological Safety Testing Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Biological Safety Testing Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Biological Safety Testing Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Biological Safety Testing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Avance Biosciences
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Cytovance Biologics
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Eurofins Scientific
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Lonza
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Merck KGaA
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Promega Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Thermo Fisher Scientific
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Toxikon
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 WuXi AppTec
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Biomerieux SA
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Nelson Laboratories, LLC
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Almac Group
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 GenScript
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 InvivoGen
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Maravai LifeSciences
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Biological Safety Testing Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us